Want to get a preview of how you can gain compelling insights from Technavio’s market research report? Check out the latest facts about the POC RSV testing industry
The global POC RSV testing market is expected to grow at a CAGR of more than 7% during the forecast period
POC RSV testing industry growth is expected to accelerate over the next five years, driven by an increase in the incidence and prevalence of RSV infections which has resulted for higher demand for RSV test procedures. The incidence rate of RSV has been on the rise across the globe owing to the ever-increasing air pollution and offsets of the seasons, which has led to temperature imbalances in the environment. According to the National Institute of Allergy and Infectious Diseases, RSV affects an estimated 64 million people and is responsible for around 160,000 deaths across the globe every year. Technavio’s POC RSV testing industry analysis reveals promising markets around the world.
Want a bigger picture? Get a free sample of this report now!
See the complete table of contents and list of exhibits, as well as selected illustrations and example pages from this report.
Americas dominated the global POC RSV testing market by geography
The largest market share in the global POC RSV testing market was held by the Americas, followed by EMEA and APAC. In addition, the Americas are forecasted to continue their dominance over the next five years, owing to rising prevalence of RSV infections coupled with a well-defined healthcare system in the region. The Americas will also make the largest contribution of almost 42% to the incremental growth of the market during the forecast period while APAC will register the fastest rate of growth among the three regions.
Get more value with Technavio’s subscription platform! Gain easy access to all Technavio’s reports, along with on-demand services. Start your 14-day FREE trial
Abbott, BD, and bioMérieux are among the leading POC RSV testing companies
The global POC RSV testing market is forecasted to witness an increasing demand for POC instruments owing to the growing incidence of RSV infections. Several POC RSV testing companies are focused on initiating various M&A strategies to develop and market POC products to meet the high volume of demand from across the globe. Many established POC RSV testing companies are vying for their share of the market, and players must differentiate themselves to gain vital traction over their peers.
This report offers a complete analysis of several POC RSV testing companies, including:
- Abbott
- BD
- bioMérieux
- F. Hoffmann-La Roche
- Thermo Fisher Scientific
Want to dial in on a specific region or segment? We can help! Our analysts can customize this report to meet your requirements. Get in touch
Table of Contents
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 03: RESEARCH METHODOLOGY
PART 04: MARKET LANDSCAPE
- Market ecosystem
- Market characteristics
- Market segmentation analysis
PART 05: MARKET SIZING
- Market definition
- Market sizing 2017
- Market size and forecast 2017-2022
PART 06: FIVE FORCES ANALYSIS
- Bargaining power of buyers
- Bargaining power of suppliers
- Threat of new entrants
- Threat of substitutes
- Threat of rivalry
- Market condition
PART 07: MARKET SEGMENTATION BY PRODUCT
- Segmentation by product
- Comparison by product
- Consumables – Market size and forecast 2017-2022
- Systems – Market size and forecast 2017-2022
- Market opportunity by product
PART 08: CUSTOMER LANDSCAPE
PART 09: REGIONAL LANDSCAPE
- Geographical segmentation
- Regional comparison
- Americas – Market size and forecast 2017-2022
- EMEA – Market size and forecast 2017-2022
- APAC – Market size and forecast 2017-2022
- Market opportunity
PART 10: DECISION FRAMEWORK
PART 11: DRIVERS AND CHALLENGES
- Market drivers
- Market challenges
PART 12: MARKET TRENDS
- Growing need for companion diagnostics
- Growing partnerships
- Technological advances
PART 13: VENDOR LANDSCAPE
- Overview
- Landscape disruption
PART 14: VENDOR ANALYSIS
- Vendors covered
- Vendor classification
- Market positioning of vendors
- Abbott
- BD
- bioMérieux
- F. Hoffmann-La Roche
- Thermo Fisher Scientific
PART 15: APPENDIX